ArticleResearch square2023

Cooperative Genomic Lesions in HRAS-Mutant Cancers Predict Resistance to Farnesyltransferase Inhibitors.

Aradhya Nigam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.